Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Nigel J Waterhouse"'
Autor:
Matthew Burge, David Goldstein, Andrew Haydon, Nick Pavlakis, Charlotte Lemech, Edward Hammond, Darryn Bampton, Keith Dredge, Michael P Brown, Andrew Clouston, Nigel J Waterhouse, Amanda C Stanley, Lucie Leveque-El Mouttie, Grace M Chojnowski
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Background Pixatimod is a unique activator of the Toll-like Receptor 9 pathway. This phase I trial evaluated safety, efficacy and pharmacodynamics of pixatimod and PD-1 inhibitor nivolumab in immunologically cold cancers.Methods 3+3 dose escalation w
Externí odkaz:
https://doaj.org/article/9084358ebd5841eb853afac834f15155
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e28018 (2011)
Protease-activated receptor-2 (PAR2) is a G protein coupled receptor (GPCR) activated by proteolytic cleavage of its amino terminal domain by trypsin-like serine proteases. This irreversible activation mechanism leads to rapid receptor desensitizatio
Externí odkaz:
https://doaj.org/article/f2ecd71eee0e488cad866f6eccbae9b5
Autor:
Charlotte Lemech, Keith Dredge, Darryn Bampton, Edward Hammond, Andrew Clouston, Nigel J Waterhouse, Amanda C Stanley, Lucie Leveque-El Mouttie, Grace M Chojnowski, Andrew Haydon, Nick Pavlakis, Matthew Burge, Michael P Brown, David Goldstein
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e006136
BackgroundPixatimod is a unique activator of the Toll-like Receptor 9 pathway. This phase I trial evaluated safety, efficacy and pharmacodynamics of pixatimod and PD-1 inhibitor nivolumab in immunologically cold cancers.Methods3+3 dose escalation wit
Autor:
Nigel J. Waterhouse, Mark J. Smyth, Ludovic Martinet, Frank Vari, Lucienne Chatenoud, Maher K. Gandhi, Sébastien Lemoine, Camille Guillerey, Kimberley Stannard
Publikováno v:
Blood Advances. 3:1681-1694
Natural killer (NK) cells are a heterogeneous population of innate lymphocytes whose potent anticancer properties make them ideal candidates for cellular therapeutic application. However, our lack of understanding of the role of NK cell diversity in
Publikováno v:
Clinical & Translational Immunology, Vol 9, Iss 10, Pp n/a-n/a (2020)
Clinical & Translational Immunology
Clinical & Translational Immunology
The tumor microenvironment is an integral player in cancer initiation, tumor progression, response and resistance to anti‐cancer therapy. Understanding the complex interactions of tumor immune architecture (referred to as ‘immune contexture’) h
Publikováno v:
Oncotarget
Cervical cancer is a malignant transformation of keratinocytes initiated by the E7 oncoprotein of human papillomavirus (HPV). These tumors are characterized by keratinocyte hyperproliferation and are often infiltrated with activated CD8 T cells. HPV
Autor:
Amanda C. Stanley, Darryn Bampton, Andrew Clouson, Nick Pavlakis, Charlotte Lemech, Keith Dredge, Matthew Burge, Nigel J. Waterhouse, David Goldstein, Andrew Haydon, Lucie Leveque-ElMouttie, Grace Chojnowski, Michael P. Brown, Edward Hammond
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundPixatimod is a novel immunomodulatory agent which stimulates dendritic cells (DC) via Toll-Like Receptor 9 (TLR9) pathway to activate natural killer (NK) cells.1 It also enhances T cell infiltration into tumors when combined with PD1 inhibi
Autor:
Kimberley A, Stannard, Sébastien, Lemoine, Nigel J, Waterhouse, Frank, Vari, Lucienne, Chatenoud, Maher K, Gandhi, Ludovic, Martinet, Mark J, Smyth, Camille, Guillerey
Publikováno v:
Blood advances. 3(11)
Natural killer (NK) cells are a heterogeneous population of innate lymphocytes whose potent anticancer properties make them ideal candidates for cellular therapeutic application. However, our lack of understanding of the role of NK cell diversity in
Autor:
Tony Rossetti, Christopher Tracey, Stephanie Diaz-Guilas, Paul N. Mainwaring, Derek N.J. Hart, Kristen J. Radford, Georgina Crosbie, Melinda Y. Hardy, Rebecca L. Prue, Rachael D’Rozario, Frank Vari, Hui Tong, Robert Coleman, Vinay Gounder, Sonia Hancock, Nigel J. Waterhouse, Hans Goossen, Peter Swindle
Publikováno v:
ResearcherID
Preclinical studies have suggested that purified populations of CD1c (BDCA-1) blood-derived dendritic cells (BDC) loaded with tumor-specific peptides may be a feasible option for prostate cancer immunotherapy. We performed an open-label dose-finding
Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells
Autor:
Elena Pera, Michael J. G. Milevskiy, Paraic A. Kenny, Daneth L. Marcial, Kunsala T. D. S. Yapa, Nigel J. Waterhouse, Silke B. Chalmers, Peter J. Cabot, Gregory R. Monteith, S. Y. N. Jamaludin, Thomas J. Gonda, Melissa A. Brown, Eloise Dray, Iman Azimi, Sarah J. Roberts-Thomson, Adrian P. Wiegmans, Kum Kum Khanna, H. Lim, Amelia A. Peters, Korinne Northwood, Felicity M. Davis
Publikováno v:
Peters, A A, Jamaludin, S Y N, Yapa, K T D S, Chalmers, S, Wiegmans, A P, Lim, H F, Milevskiy, M J G, Azimi, I, Davis, F M, Northwood, K S, Pera, E, Marcial, D L, Dray, E, Waterhouse, N J, Cabot, P J, Gonda, T J, Kenny, P A, Brown, M A, Khanna, K K, Roberts-Thomson, S J & Monteith, G R 2017, ' Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells ', Oncogene, bind 36, nr. 46, s. 6490-6500 .
Aarhus University
Aarhus University
The critical role of calcium signalling in processes related to cancer cell proliferation and invasion has seen a focus on pharmacological inhibition of overexpressed ion channels in specific cancer subtypes as a potential therapeutic approach. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59b21e309ab6df992517676a5de65abc
https://hdl.handle.net/11541.2/133849
https://hdl.handle.net/11541.2/133849